Experience

Sun Yat-sen University

• Research
• 500 - 600 Employee

• Independent Unblinded Statistician

  • Jan 2020 - Present

  • Participated in Covid-19 Vaccine Development and Provided DSMB Statistical Analysis Reports• Participated in Oncology Medicine Development and Provided iDMC Statistical Analysis Reports

• Associate Professor

  • Apr 2018 - Present

  • Teaching undergraduate and graduate courseso Mathematical Statistics, Multivariate Statistics, Machine Learning, Complex Data Analysis• Conducting Academic Researcho Statistical Inference: Equivariance Principle and Its Usage in Linear Model and Multivariate Analysiso Precision Medicine: Big Data Analysis and Optimal Treatment Regimeo Survival Analysis: A Novel Statistical Theory and Its applications on Oncology Clinical Trialso Privacy and Confidentiality Protection and Its Implications in Design and Analysis Show less



MSD

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Sr. Scientist, Biostatistics

  • Jan 2015 - Apr 2018

  Worked on Phase I & III Drug Development Projects in CV, Oncology and Vaccine areas: Authoring protocols, Conducting Analysis & Report Activities and Supporting Publications o HPV vaccine Gardasil in mid-aged women and men o Phase I Study of Pembrolizumab in Chinese Subjects with Non-Small-Cell Lung Cancer o Diabetes • Conducted research on Multiple Region Clinical Trial Worked on Phase I & III Drug Development Projects in CV, Oncology and Vaccine areas: Authoring protocols, Conducting Analysis & Report Activities and Supporting Publications o HPV vaccine Gardasil in mid-aged women and men o Phase I Study of Pembrolizumab in Chinese Subjects with Non-Small-Cell Lung Cancer o Diabetes • Conducted research on Multiple Region Clinical Trial



Duke University Medical Center

• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral Associate

  • Aug 2013 - Aug 2014

  Worked on prostate cancer trials data analysis Developed related methodologies in survival analysis Worked on prostate cancer trials data analysis Developed related methodologies in survival analysis



The Ohio State University

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Researcher

  • Oct 2011 - Jul 2013

  • Applied random forests method to analyze high dimensional data for a pharmaceutical classification project of toxicity of chemical compounds • Leveraged nonparametric methods to improve accuracy and introduced dimension reduction • Developed weight-of-evidence approaches to estimate and detect uncertainties in predictions • Applied random forests method to analyze high dimensional data for a pharmaceutical classification project of toxicity of chemical compounds • Leveraged nonparametric methods to improve accuracy and introduced dimension reduction • Developed weight-of-evidence approaches to estimate and detect uncertainties in predictions



FDA

• United States
• Government Administration
• 700 & Above Employee

• Intern

  • Jun 2008 - Aug 2008

  Oncology Group, Office of Biostatistics. Projects on relationship between Overall surivival and Progression-free survival under oncology setting. Oncology Group, Office of Biostatistics. Projects on relationship between Overall surivival and Progression-free survival under oncology setting.